By Matthew Lee | Associated Press
WASHINGTON — The sale to a Russian company of a Canadian firm with rights to mine U.S. uranium is again in the news with the Department of Justice signaling it could appoint a special counsel to look into the matter.
Sessions denies lying, now recalls Russia interaction
Fact check: Trump tells head-scratcher about Air Force One
State of democracy in Mexico will be subject of UC Berkeley talk
Trump largely ignores human rights on Asia trip
Trump Jr. reportedly messaged with Wikileaks during campaign
President Donald Trump and his supporters have criticized the deal, which attracted little attention when it was approved by the Obama administration, and suggested it may implicate former Secretary of State Hillary Clinton in wrongdoing.
Those allegations have been repeatedly denied by Clinton’s camp and former Obama administration officials. In addition, independent fact-checkers have found some of the critics’ allegations to be flawed or misrepresented.
A look at the sale of Uranium One to Russia’s nuclear energy agency Rosatom.
Rosatom acquired a majority stake in Uranium One in 2010 and bought the remainder of the company in 2013. Because Uranium One had holdings in American uranium mines, which at the time accounted for about 20 percent of America’s licensed uranium mining capacity, Rosatom’s 2010 purchase had to be approved by the Committee on Foreign Investment in the United States. That committee, known as CFIUS, is made up of officials from nine federal agencies, including the State Department, which Clinton ran at the time. Other agencies represented on the committee include the departments of Treasury, Defense, Commerce, Energy and Homeland Security and the Office of the U.S. Trade Representative.
Trump and his supporters have accused Clinton of overseeing the sale of 20 percent of America’s uranium supply to Russia. They see her alleged role as a scandal, particularly amid charges the Trump campaign colluded with Russia in the 2016 presidential election. Allegations have also been made that the approval of the sale of Uranium One benefited major donors to the Clinton Foundation, raising conflict-of-interest questions.
The matter took on new life after a report last month said the FBI was …read more
Source:: East Bay – National & World